SILO on Nasdaq

Silo Pharma, Inc.

Given the global Alzheimer’s therapeutics market is projected to exceed $30.8 billion by 2033, SPC-14 presents a promising opportunity.3 From its latest annual report

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Oncotelic Therapeutics, Inc., Benitec Biopharma Ltd or Inovio Pharmaceuticals, or pick any stock.

  • TickerSILO on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSarasota, Florida1
  • Incorporated inNV2
  • Business address677 N. Washington Blvd, Sarasota, Fl 342362
  • Filer categoryNon-accelerated filer, Smaller reporting company2
  • Legal formCorporation

See how the biggest companies compare on our leaderboards

Given the global Alzheimer’s therapeutics market is projected to exceed $30.8 billion by 2033, SPC-14 presents a promising opportunity.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

38.6%Gross margin4
-5937.0%Operating margin4
-5863.5%Net margin4
0.0%Revenue growth, 20254
-67.0%Return on equity4

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue2¢$44.3K
  • Research and development98¢$2.2M

Out of $72.1K in revenue.4 The company lost money this year.

Financial statements

Revenue5674$72.1K in 2025+78% since 2019
0$20.0K$40.0K$60.0K$80.0K2019: $40.6K$40.6K20192020: $40.9K$40.9K2020+1%2022: $72.1K$72.1K2022+76%2023: $72.1K$72.1K2023+0%2024: $72.1K$72.1K2024+0%2025: $72.1K$72.1K2025+0%
Gross profit58674$27.8K in 2025+111% since 2019
-$200.0K-$100.0K0$100.0K2019: $13.2K$13.2K20192020: -$135.2K-$135.2K20202021: $66.3K$66.3K20212022: $66.3K$66.3K2022+0%2023: $66.3K$66.3K2023+0%2024: $66.3K$66.3K2024+0%2025: $27.8K$27.8K2025−58%
Operating income598674-$4.3M in 2025+360% since 2019
-$6.0M-$4.0M-$2.0M02019: -$930.4K-$930.4K20192020: -$2.2M-$2.2M2020+137%2021: -$2.7M-$2.7M2021+25%2022: -$3.6M-$3.6M2022+32%2023: -$3.9M-$3.9M2023+6%2024: -$4.7M-$4.7M2024+22%2025: -$4.3M-$4.3M2025−9%
Net income598674-$4.2M in 2025+317% since 2019
-$5.0M-$2.5M0$2.5M$5.0M2019: -$1.0M-$1.0M20192020: -$3.0M-$3.0M2020+200%2021: $3.9M$3.9M20212022: -$3.9M-$3.9M20222023: -$3.7M-$3.7M2023−5%2024: -$4.4M-$4.4M2024+19%2025: -$4.2M-$4.2M2025−4%
Fiscal year2019202020212022202320242025
Revenue$40.6K5$40.9K5$72.1K6$72.1K7$72.1K4$72.1K4
Cost of revenue$27.4K5$176.1K5$5.0K8$5.8K6$5.8K7$5.8K4$44.3K4
Gross profit$13.2K5-$135.2K5$66.3K8$66.3K6$66.3K7$66.3K4$27.8K4
Research and development$26.2K9$693.9K8$1.3M6$845.1K7$2.4M4$2.2M4
Selling, general and admin$50.2K9$163.0K8$227.3K6$390.1K6
Operating expenses$2.8M8$3.7M6$3.9M7$4.8M4$4.3M4
Operating income-$930.4K5-$2.2M9-$2.7M8-$3.6M6-$3.9M7-$4.7M4-$4.3M4
Interest$05$809$3.0K8$2.2K6$4.9K6
Income before tax$4.2M8-$3.9M6-$3.6M7-$4.4M4-$4.2M4
Income tax$24.9K8
Net income-$1.0M5-$3.0M9$3.9M8-$3.9M6-$3.7M7-$4.4M4-$4.2M4
Earnings per share-$0.059$0.049-$1.207-$1.194-$0.504
Earnings per share (diluted)-$0.059$0.049-$1.207-$1.194-$0.504
Shares (weighted, basic)1.9M shares82.3M shares63.1M shares73.7M shares48.4M shares4
Shares (weighted, diluted)1.9M shares82.3M shares63.1M shares73.7M shares48.4M shares4

Compare Silo Pharma, Inc. with another company

Leadership

Who has led Silo Pharma, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Melvin Schlossberg2013
  2. Richard Brand2014
  3. Eric Weisblum2020–now

Chair

  1. Richard Brand2014

President

  1. Melvin Schlossberg2013
  2. Eric Weisblum2014–now

Chief financial officer

  1. Donald Ptalis2013
  2. Adam C. Wasserman2016
  3. Eric Weisblum2021–2022
  4. Daniel E. Ryweck2022–now
201520202025
Board members and other officers (11)

Former names

  • Uppercut Brands, Inc.Aug 13, 2019 to Aug 14, 20202
  • Point Capital, Inc.Jan 30, 2013 to May 14, 20192
  • Gold Swap IncMar 30, 2011 to Jan 7, 20132

Timeline

  1. Apr 30, 2020New chief executive Eric Weisblum becomes CEO12
  2. Aug 1, 2014New chief executive Richard Brand becomes CEO13
  3. Jan 7, 2013New chief executive Melvin Schlossberg becomes CEO14

Filings

203 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 53 major events, 32 insider forms, 17 large holders, 3 private raises, 78 other. The latest 20:

  1. Oct 14, 20268-K CURRENT REPORT EDGAR
  2. Oct 2, 20268-K CURRENT REPORT EDGAR
  3. Aug 19, 20268-K CURRENT REPORT EDGAR
  4. Aug 17, 20268-K CURRENT REPORT EDGAR
  5. Aug 13, 202610-Q QUARTERLY REPORT EDGAR
  6. Aug 13, 2026SCHEDULE 13G/A EDGAR
  7. Aug 6, 2026EFFECT EDGAR
  8. Aug 6, 2026424B3 PROSPECTUS EDGAR
  9. Jul 31, 2026S-8 REGISTRATION STATEMENT EDGAR
  10. Jul 24, 2026S-3 REGISTRATION STATEMENT EDGAR
  11. Jul 14, 2026D EDGAR
  12. Jul 13, 20268-K CURRENT REPORT EDGAR
  13. Jul 8, 2026SCHEDULE 13G EDGAR
  14. Jun 30, 2026ARS EDGAR
  15. Jun 30, 2026DEFA14A DEFINITIVE ADDITIONAL MATERIALS EDGAR
  16. Jun 30, 2026DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
  17. Jun 18, 20268-K CURRENT REPORT EDGAR
  18. Jun 18, 2026PRE 14A DEFINITIVE PROXY STATEMENT EDGAR
  19. Jun 3, 20268-K CURRENT REPORT EDGAR
  20. Jun 1, 20268-K CURRENT REPORT EDGAR

The 203 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

40 open-market trades by officers, directors and large owners since October 2021: 40 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Dec 15, 2025Weisblum EricChief Executive OfficerBuy5,000$0.41$2.1KForm 4
Nov 21, 2025Weisblum EricChief Executive OfficerBuy1,000$0.37$370Form 4
Nov 20, 2025Weisblum EricChief Executive OfficerBuy1,000$0.37$370Form 4
Nov 19, 2025Weisblum EricChief Executive OfficerBuy4,500$0.41$1.8KForm 4
Nov 18, 2025Weisblum EricChief Executive OfficerBuy7,500$0.40$3.0KForm 4
May 27, 2025Weisblum EricChief Executive OfficerBuy10,000$0.43$4.3KForm 4
Dec 13, 2024Weisblum EricChief Executive OfficerBuy2,500$0.84$2.1KForm 4
Nov 22, 2024Weisblum EricChief Executive OfficerBuy2,500$0.90$2.2KForm 4
Nov 20, 2024Weisblum EricChief Executive OfficerBuy2,500$0.95$2.4KForm 4
Jun 12, 2024Weisblum EricChief Executive OfficerBuy4,438$1.11$4.9KForm 4
Jun 11, 2024Weisblum EricChief Executive OfficerBuy562$1.08$607Form 4
Apr 5, 2024Weisblum EricChief Executive OfficerBuy400$2.03$812Form 4
Apr 4, 2024Weisblum EricChief Executive OfficerBuy600$1.96$1.2KForm 4
Apr 1, 2024Weisblum EricChief Executive OfficerBuy1,100$1.91$2.1KForm 4
Mar 28, 2024Weisblum EricChief Executive OfficerBuy3,408$1.94$6.6KForm 4
Dec 20, 2023Weisblum EricChief Executive OfficerBuy200$1.61$322Form 4
Dec 19, 2023Weisblum EricChief Executive OfficerBuy500$1.63$815Form 4
Dec 15, 2023Weisblum EricChief Executive OfficerBuy900$1.52$1.4KForm 4
Dec 14, 2023Weisblum EricChief Executive OfficerBuy200$1.50$300Form 4
Dec 7, 2023Weisblum EricChief Executive OfficerBuy324$1.36$441Form 4

All 40 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Jul 9, 2026Raised $4 million in a private offering of equity Form D: 4 investors so far Form D
  2. Jul 18, 2024Raised $2.3 million in a private offering of equity Form D: 2 investors so far Form D
  3. Jun 4, 2024Raised $2.1 million in a private offering of equity Form D: 3 investors so far Form D

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
AdvisorShares Investments LLC75,582$469.4K0.1%New
Citadel Advisors LLC16,800$104.3K0.0%New
Vanguard Capital Management LLC11,956$74.2K0.0%New
Vanguard Fiduciary Trust Co874$5.4K0.0%New
Tower Research Capital LLC (TRC)181$1.1K0.0%New
Harbour Investments, Inc.14$870.0%New
Citigroup Inc1$60.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32